CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD

Overview

CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 16 active FDA Type II Drug Master Files, covering BENIDIPINE HYDROCHLORIDE; BILASTINE; CALCIPOTRIOL ANHYDROUS; CALCIPOTRIOL MONOHYDRATE; CALCIUM LEVOFOLINATE HYDRATE; CRIZOTINIB.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD holds 18 active (18 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ELACESTRANT DIHYDROCHLORIDEActive2026-06-29
• NINTEDANIB ESYLATEActive2026-06-23
• ISONIAZIDActive2026-02-24
• RUXOLITINIB PHOSPHATEActive2026-02-12
• BENIDIPINE HYDROCHLORIDEActive2025-12-24
• BILASTINEActive2025-08-11
• UPADACITINIB HEMIHYDRATEActive2025-06-05
• PERFLUOROHEXYLOCTANEActive2025-04-02
• ENZALUTAMIDEActive2025-04-01
• FINERENONEActive2025-03-17
• CALCIUM LEVOFOLINATE HYDRATEActive2025-01-24
• POSACONAZOLEActive2024-12-18
• FULVESTRANTActive2024-11-29
• NINTEDANIB ESILATEActive2024-10-31
• CRIZOTINIBActive2024-05-31

Showing 15 of 18 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.